contacts Sign In
image
author Image

GSK expects RSV vaccine uptake will be slower than shingles vaccine-CEO

  • Home
  • Healthcare
  • GSK expects RSV vaccine uptake will be slower than shingles vaccine-CEO
The company has said it expects the inoculation to be a major driver of future sales to offset the loss of patent protection for some of its key HIV medicines later this decade.